Medication info

Huriamin HB-C Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.76g / 100mLL-Leucine›1.37g / 100mLL-Lysine Acetate›0.58g / 100mLL-Methionine›0.25g / 100mLL-Phenylalanine›0.32g / 100mLL-Threonine›0.2g / 100mLL-Tryptophan›0.09g / 100mLL-Valine›0.88g / 100mLL-Alanine›0.4g / 100mLL-Arginine›0.58g / 100mLL-Histidine›0.16g / 100mLL-Proline›0.63g / 100mLL-Serine›0.33g / 100mLGlycine›0.33g / 100mL
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
This medication is a transparent solution that is colorless to slightly yellow, contained in a polypropylene aqueous injection vial.
Packaging
100mL/pack
Approval status
Active

MFDS item code 199304469 · Notified 1993.03.09

Summary

Main use
Improvement of nutritional status (hypoproteinemia, pre- and postoperative conditions, etc.) through amino acid supplementation
Who uses it
Adults · Children
Adult dosage
○ Adults: Administer by intravenous drip infusion, up to a maximum of 1~1.5 g of total amino acids per kg of body weight daily. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general rule is to infuse at a rate of 30~40 drops per minute.
Children's dosage
In children, elderly patients, burn patients with high protein requirements, and similar patients, adjust the dose and infusion rate for administration.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of nutritional status (hypoproteinemia, pre- and postoperative conditions, etc.) through amino acid supplementation

  • Hypoproteinemia
  • malnutrition
View approved original text

This medication is used when amino acid supplementation is needed for hypoproteinemia, malnutrition, and conditions such as pre-and post-surgery. In these situations, the body may not receive sufficient protein, delaying recovery; thus, amino acids are supplemented to improve nutritional status and promote recovery. Therefore, this medicine is used in cases of hypoproteinemia, nutritional deficiency states, and recovery periods before and after surgery.

Dosage and Administration

Adult dosage

○ Adults: Administer by intravenous drip infusion, up to a maximum of 1~1.5 g of total amino acids per kg of body weight daily. ○ Infusion rate: A concentration of approximately 10 g of total amino acids over 60 minutes is preferred, and the general rule is to infuse at a rate of 30~40 drops per minute.

Children's dosage

In children, elderly patients, burn patients with high protein requirements, and similar patients, adjust the dose and infusion rate for administration.

Precautions

This medication must only be used according to a doctor's instructions. It should not be administered to patients with hepatic coma or at risk of hepatic coma, severe renal impairment, problems with nitrogen metabolism, patients with catabolic heart failure or pulmonary edema, and to those whose urine output is minimal or absent. Additionally, if sodium or chloride ions are present, it should not be administered to patients with hypernatremia, hyperchloremia, or alkaline disorders. If magnesium ions are included, it should be avoided in patients with complete heart block or severe myasthenia. Patients with hypersensitivity to amino acids contained in this medication, those with hyperkalemia, and patients with a history of myocardial infarction should not receive it. Patients with severe acidosis, congestive heart failure, edema due to sodium retention, and liver or kidney disorders should use this medication with caution. This drug contains sodium bisulfite, which can trigger allergic reactions or asthma attacks; therefore, asthmatic patients should be particularly careful. During use, various adverse reactions such as skin rash, nausea, vomiting, palpitations, and elevated blood pressure may occasionally occur, so symptoms should be immediately reported to medical personnel. Rapid large volume administration may lead to acidosis, and severe symptoms such as chills, fever, headache, and dyspnea may rarely occur. When administering this drug, careful monitoring of electrolyte balance is required; especially in patients with impaired kidney or liver function, it should be administered cautiously to prevent fluid overload. Diabetic patients should regularly check their blood sugar levels, and since ketosis may occur when only amino acid solutions are administered, it is advisable to also provide carbohydrates. Regular tests for blood sugar, electrolytes, and liver and kidney function should be performed to closely monitor the condition. When combining with other medications, there may be interactions, especially when used with tetracyclines or calcium salts. Safety has not been established in pregnant women, so it should only be administered when the therapeutic benefit outweighs the risk. When administering to children, be mindful that liver function may be immature, so keep the concentration low and check blood ammonia levels frequently. In the elderly, due to decreased physiological function, administration should be done slowly and dosages adjusted. When administering, pay attention to electrolyte content and infusion speed; rapid infusion may cause chills or vomiting, so administer slowly. Preparation and management of intravenous fluids should be done in a sterile manner, and before administration, the solution should be checked for clarity and abnormalities should prevent its use.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • increased blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • shortness of breath
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress. It is also important to store it in a place away from direct sunlight at normal room temperature, avoiding extremely hot or cold conditions.

Appearance and packaging

Appearance

This medication is a transparent solution that is colorless to slightly yellow, contained in a polypropylene aqueous injection vial.

Package unit

100mL/pack

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.